Differential expression of FosB, c-Fos, and Zif268 in forebrain regions after acute or chronic l-DOPA treatment in a rat model of Parkinson's disease

Neuroscience Letters

Volumn 496, Issue 2, 2011, Pages 90-94

  Ebihara, Kosuke ^a   Ishida, Yasushi ^a   Takeda, Ryuichiro ^a   Abe, Hiroshi ^a   Matsuo, Hisae ^a   Kawai, Keiichi ^b   Magata, Yasuhiro ^c   Nishimori, Toshikazu ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

6 Hydroxydopamine; Abnormal involuntary movement; Immediate early gene protein; Immunohistochemistry; L DOPA

Indexed keywords

BENSERAZIDE; BENSERAZIDE PLUS LEVODOPA; IMMEDIATE EARLY PROTEIN; IMMEDIATE EARLY PROTEIN ZIF 268; LEVODOPA METHYL ESTER; METHAMPHETAMINE; OXIDOPAMINE; PROTEIN C FOS; SODIUM CHLORIDE; TRANSCRIPTION FACTOR FOSB; UNCLASSIFIED DRUG;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CINGULATE; ARTICLE; BASOLATERAL AMYGDALA; CAUDATE NUCLEUS; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG INDUCED DISEASE; DYSKINESIA; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PUTAMEN; RAT;

ACUTE DISEASE; ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION REGULATION; LEVODOPA; MALE; PARKINSONIAN DISORDERS; PROSENCEPHALON; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

EID: 79955729001     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.03.087     Document Type: Article

References (25)

1. Alheid G.F., Heimer L. New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata. Neuroscience 1988, 27:1-39.
2. Andersson M., Hilbertson A., Cenci M.A. Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease. Neurobiol. Dis. 1999, 6:461-474.
3. Andersson M., Konradi C., Cenci M.A. cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum. J. Neurosci. 2001, 21:9930-9943.
4. Carta A.R., Tronci E., Pinna A., Morelli M. Different responsiveness of striatonigral and striatopallidal neurons to l-DOPA after a subchronic intermittent l-DOPA treatment. Eur. J. Neurosci. 2005, 21:1196-1204.
5. Cenci M.A. Transcription factors involved in the pathogenesis of l-DOPA-induced dyskinesia in a rat model of Parkinson's disease. Amino Acids 2002, 23:105-109.
6. Cenci M.A., Lee C.S., Björklund A. l-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. Eur. J. Neurosci. 1998, 10:2694-2706.
7. Cenci M.A., Lindgren H.S. Advances in understanding l-DOPA-induced dyskinesia. Curr. Opin. Neurobiol. 2007, 17:665-671.
8. Cenci M.A., Tranberg A., Andersson M., Hilbertson A. Changes in the regional and compartmental distribution of FosB- and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic l-DOPA treatment. Neuroscience 1999, 94:515-527.
9. Chen J., Kelz M.B., Hope B.T., Nakabeppu Y., Nestler E.J. Chronic Fos-related antigens: stable variants of deltaFosB induced in brain by chronic treatments. J. Neurosci. 1997, 17:4933-4941.
10. Cole D.G., Growdon J.H., DiFiglia M. Levodopa induction of Fos immunoreactivity in rat brain following partial and complete lesions of the substantia nigra. Exp. Neurol. 1993, 120:223-232.
11. Doucet J.P., Nakabeppu Y., Bedard P.J., Hope B.T., Nestler E.J., Jasmin B.J., Chen J.S., Iadarola M.J., St-Jean M., Wigle N., Blanchet P., Grondin R., Robertson G.S. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum. Eur. J. Neurosci. 1996, 8:365-381.
12. Everitt B.J., Parkinson J.A., Olmstead M.C., Arroyo M., Robledo P., Robbins T.W. Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems. Ann. N. Y. Acad. Sci. 1999, 877:412-438.
13. Fornito A., Yücel M., Dean B., Wood S.J., Pantelis C. Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology. Schizophr. Bull. 2009, 35:973-993.
14. Friedman A., Sienkiewicz J. Psychotic complications of long-term levodopa treatment of Parkinson's disease. Acta Neurol. Scand. 1991, 84:111-113.
15. Henry B., Crossman A.R., Brotchie J.M. Effect of repeated l-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat. Exp. Neurol. 1999, 155:204-220.
16. Ishida Y., Hashiguchi H., Todaka K., Kuwahara I., Ishizuka Y., Nakane H., Uchimura D., Nishimori T., Mitsuyama Y.Y. Serotonergic activity in the rat striatum after intrastriatal transplantation of fetal nigra as measured by microdialysis. Brain Res. 1998, 788:207-214.
17. Ishida Y., Kawai K., Magata Y., Ebihara K., Takeda R., Abe H., Yoshimoto M., Hashiguchi H., Odagiri K., Matsuo H., Nishimori T. Differential expression of Fos and Zif268 in the nigrostriatal system after methamphetamine administration in a rat model of Parkinson's disease. Synapse 2008, 62:920-926.
18. Iyo M., Sekine Y., Mori N. Neuromechanism of developing methamphetamine psychosis: a neuroimaging study. Ann. N. Y. Acad. Sci. 2004, 1025:288-295.
19. Kalivas P.W., McFarland K. Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berl.). 2003, 168:44-56.
20. König J.F.R., Klippel R.A. The Rat Brain. A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem 1963, Williams and Wilkins, Baltimore.
21. Morgan J.I., Curran T. Immediate-early genes: ten years on. Trends Neurosci. 1995, 18:66-67.
22. Paus T. Primate anterior cingulate cortex: where motor control, drive and cognition interface. Nat. Rev. Neurosci. 2001, 2:417-424.
23. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1997, Academic Press, San Diego.
24. Voon V., Fernagut P.O., Wickens J., Baunez C., Rodriguez M., Pavon N., Juncos J.L., Obeso J.A., Bezard E. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders. Lancet Neurol. 2009, 8:1140-1149.
25. Winkler C., Kirik D., Björklund A., Cenci M.A. l-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of Parkinson's disease: relation to motor and cellular parameters of nigrostriatal function. Neurobiol. Dis. 2002, 10:165-186.